Skip to content

The Muscle Protein Synthetic Response of Algal and Fungal Protein

The Muscle Protein Synthetic Response Following the Ingestion of a Single Bolus of Algal Protein When Compared to Fungal Protein in Healthy Young Adults

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05016557
Acronym
SCAM
Enrollment
36
Registered
2021-08-23
Start date
2020-12-19
Completion date
2022-06-24
Last updated
2024-01-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Muscle Metabolism

Keywords

Amino Acids, Protein metabolism, Resistance exercise, Muscle protein synthesis

Brief summary

Dietary protein intake is vital for the maintenance of skeletal muscle mass and health. The production of animal-based proteins sources is associated with growing environmental and ethical challenges. As such, sustainable alternatives are needed. Algae are sustainably produced high-protein sources and it is predicted that algae will become one of the most consumed proteins in the next decades. However, the effects of algae on the stimulation of muscle mass growth are unknown. Therefore, we aim to assess the rate of digestion and absorption, and the effects on muscle growth of two types of algae (spirulina and chlorella) when compared to a sustainable non-animal derived fungal reference protein (mycoprotein), a source known to elicit a robust anabolic response.

Interventions

DIETARY_SUPPLEMENTProtein ingestion

Bolus ingestion of 25g protein

Sponsors

University of Exeter
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

* BMI between 18.5 and 30 * Recreationally active (\<3 times per week structured resistance exercise training)

Exclusion criteria

* Any metabolic impairment * Any cardiovascular impairment * High blood pressure (\>140/90 mmHg) * A personal history of epilepsy, seizures or schizophrenia * Smoking * Chronic (\>1 month) use of over the counter pharmaceuticals * Chronic (\>2 months) use of amino acid or protein supplements * Allergic to Quorn/mycoprotein or algae products

Design outcomes

Primary

MeasureTime frameDescription
Muscle Protein Synthesis7.5 hoursThe rate of synthesis of new muscle protein (Fractional Synthetic Rate %/h)

Secondary

MeasureTime frameDescription
Plasma Amino Acid Kinetics7.5 hoursThe rate of appearance of amino acid ingested in the drink
Serum Insulin7.5 hoursBasal and postprandial concentrations of serum insulin
Blood Glucose7.5 hoursBasal and postprandial concentrations of blood glucose
mTOR phosphorylation7.5 hoursThe amount of mTOR that has been activated in the muscle cell

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026